ProAssurance Corporation
NYSE:PRAInsurance - Property & Casualty
+$0.00 today
- Market cap
- $1.29B
- Beta
- 0.04
- P/E (TTM)
- 19.4
- EPS (TTM)
- $1.27
Volume 0.00M
Average 0.93M
PRA EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
ProAssurance CorporationNYSE: PRA
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA growth accelerates
Q1 FY2026 EBITDA of $17.2M rose 548.9% year over year, ahead of the +35.3% change in trailing-twelve-month EBITDA. Sequentially, it fell 68.6% from the prior quarter. Over 3 fiscal years it compounded at +26.9% a year.
Context
- EBITDA amounted to 9.7% of revenue in FY2025, up 0.6 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of $77.72M (-27.1%) for the fiscal year ending Dec 2026, a slowdown from the +3.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $17.2M-68.6% QoQ
- Last fiscal yearDec 2025
- $106.6M+3.3% YoY
- LTMMar 2026
- $121.14M+35.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +548.9% | -46.0% | -594.9 pp |
| 1 year | +3.3% | -27.1% | -30.4 pp |
| 3-year CAGR | +26.9% | -12.4% | -39.3 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 106.6M USD
- Year-over-year change
- +3.3%
- 4-year CAGR
- -14.9%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 106.6M | +3.3% |
| FY2024 | 2024-12-31 | 103.17M | +930.1% |
| FY2023 | 2023-12-31 | 10.02M | -80.8% |
| FY2022 | 2022-12-31 | 52.22M | -74.3% |
| FY2021 | 2021-12-31 | 203.57M | — |
EBITDA vs competitors
How PRA compares with its peers on the latest reported figures
- PRA's LTM Mar 2026 EBITDA of $121.14M is the 6th highest of the 11 companies compared; the peer median is $114.23M.
- Its year-over-year change of +35.3% is the 5th highest of 11, against a peer median of +18.7%.
- EBITDA amounts to 11.2% of revenue for PRA, versus a peer median of 22.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $672.68M | +14.6% | +24.1% | 12.4% | |
| LTM Mar 2026 | $200.03M | +22.8% | +16.4% | 31.5% | |
| LTM Mar 2026 | $182.15M | +192.9% | -9.9% | 24.5% | |
| LTM Mar 2026 | $155.16M | +43.2% | -10.5% | 21.1% | |
| LTM Mar 2026 | $128.9M | +1296.5% | +66.3% | 45.2% | |
| LTM Mar 2026 | $121.14M | +35.3% | +26.9% | 11.2% | |
| LTM Mar 2026 | $99.57M | +7.8% | +13.8% | 37.7% | |
| LTM Mar 2026 | $93.41M | -8.5% | +26.5% | 7.4% | |
| LTM Mar 2026 | $91.9M | -12.8% | — | 5.9% | |
| LTM Mar 2026 | $27.17M | +258.4% | — | 9.1% | |
| LTM Mar 2025 | -$173.94M | -253.0% | — | 418.3% | |
| Peer median (excluding PRA) | $114.23M | +18.7% | +16.4% | 22.8% | |
Competitors are the stored peer set for PRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.08B | 1.1B | 1.13B | 1.13B | 1.1B |
| Cost of Revenue | 862.85M | 909.94M | 935.31M | 874.87M | 665.42M |
| Gross Profit | 212.58M | 191.86M | 195.11M | 253.34M | 432.61M |
| Gross Margin | 19.8% | 17.4% | 17.3% | 22.5% | 39.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 65.98M | 198.08M | 234.26M | 190.26M | 360.54M |
| Depreciation & Amortization | 37.25M | 38.06M | 26.02M | 17.75M | 13.69M |
| EBITDA | 203.57M | 52.22M | 10.02M | 103.17M | 106.6M |
| EBITDA Margin | 18.9% | 4.7% | 0.9% | 9.1% | 9.7% |
| Operating Income | 146.61M | (6.22M) | (39.15M) | 63.08M | 72.07M |
| Operating Margin | 13.6% | -0.6% | -3.5% | 5.6% | 6.6% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 19.72M | 20.37M | 23.15M | 22.34M | 20.84M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 146.61M | (6.22M) | (39.15M) | 63.08M | 72.07M |
| Pre-Tax Margin | 13.6% | -0.6% | -3.5% | 5.6% | 6.6% |
| Income Tax Expense | 2.48M | (5.81M) | (545K) | 10.33M | 21.15M |
| Net Income | 144.12M | (402K) | (38.6M) | 52.74M | 50.92M |
| Net Margin | 13.4% | -0.0% | -3.4% | 4.7% | 4.6% |
| EPS (Basic) | 2.67 | (0.01) | (0.73) | 1.03 | 0.99 |
| EPS (Diluted) | 2.67 | (0.01) | (0.73) | 1.03 | 0.99 |
| Weighted Avg Shares | 53.96M | 54.01M | 52.64M | 51.1M | 51.34M |
| Weighted Avg Shares (Diluted) | 54.06M | 54.14M | 52.79M | 51.27M | 51.67M |
ProAssurance Corporation
NYSE:PRA
Intrinsic Alpha fair value
Locked
Current Price
$25.00
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.